Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial (Q44914002)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial |
scientific article |
Statements
1 reference
Treatment of symptomatic diabetic peripheral neuropathy with the protein kinase C beta-inhibitor ruboxistaurin mesylate during a 1-year, randomized, placebo-controlled, double-blind clinical trial (English)
1 reference
1 reference
Vera Bril
1 reference
Aaron I Vinik
1 reference
Peter Kempler
1 reference
William J Litchy
1 reference
Karen L Price
1 reference
Edward J Bastyr
1 reference
MBBQ Study Group
1 reference
1 August 2005
1 reference
1 reference
Identifiers
1 reference